Credit Suisse’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$5.96M Sell
562,172
-120,146
-18% -$1.05M 0.01% 1195
2023
Q4
$5.47M Buy
682,318
+105,748
+18% +$770K 0.01% 1282
2023
Q3
$4.74M Buy
576,570
+10,041
+2% +$86.6K ﹤0.01% 1299
2023
Q2
$4.53M Buy
566,529
+92,649
+20% +$683K ﹤0.01% 1403
2023
Q1
$3.84M Buy
473,880
+26,671
+6% +$214K ﹤0.01% 1490
2022
Q4
$2.81M Sell
447,209
-54,326
-11% -$379K ﹤0.01% 1689
2022
Q3
$3.46M Sell
501,535
-49,831
-9% -$346K ﹤0.01% 1486
2022
Q2
$4.61M Buy
551,366
+157,870
+40% +$2.21M ﹤0.01% 1332
2022
Q1
$8.99M Sell
393,496
-29,489
-7% -$721K 0.01% 1090
2021
Q4
$11.7M Sell
422,985
-10,870
-3% -$291K 0.01% 1387
2021
Q3
$12.1M Sell
433,855
-194,382
-31% -$5.51M 0.01% 1409
2021
Q2
$18.3M Buy
628,237
+91,787
+17% +$2.78M 0.01% 1186
2021
Q1
$17M Sell
536,450
-132,332
-20% -$3.88M 0.01% 1255
2020
Q4
$13.9M Sell
668,782
-258,864
-28% -$4.83M 0.01% 1379
2020
Q3
$14.4M Buy
927,646
+26,993
+3% +$465K 0.01% 1183
2020
Q2
$16.5M Sell
900,653
-674,705
-43% -$11.9M 0.01% 1043
2020
Q1
$24.4M Buy
1,575,358
+790,096
+101% +$19.1M 0.02% 738
2019
Q4
$23.5M Buy
785,262
+141,201
+22% +$3.67M 0.02% 936
2019
Q3
$14.1M Sell
644,061
-171,523
-21% -$3.92M 0.01% 1117
2019
Q2
$20.6M Buy
815,584
+176,548
+28% +$4.19M 0.02% 913
2019
Q1
$15.8M Sell
639,036
-720,506
-53% -$17.2M 0.01% 989
2018
Q4
$25.1M Buy
1,359,542
+76,582
+6% +$1.82M 0.03% 673
2018
Q3
$32.9M Buy
1,282,960
+316,168
+33% +$7.24M 0.03% 609
2018
Q2
$22.5M Sell
966,792
-471,578
-33% -$9.75M 0.02% 776
2018
Q1
$22.9M Buy
1,438,370
+120,575
+9% +$2.24M 0.02% 778
2017
Q4
$27.4M Buy
1,317,795
+302,215
+30% +$4.79M 0.02% 715
2017
Q3
$14.6M Buy
1,015,580
+39,630
+4% +$599K 0.01% 1025
2017
Q2
$16.9M Buy
975,950
+86,995
+10% +$1.04M 0.02% 901
2017
Q1
$9.8M Sell
888,955
-36,732
-4% -$505K 0.01% 1236
2016
Q4
$13.4M Buy
925,687
+79,957
+9% +$1.47M 0.01% 1034
2016
Q3
$20.8M Sell
845,730
-126,889
-13% -$3.28M 0.02% 803
2016
Q2
$19.6M Buy
972,619
+322,987
+50% +$9.15M 0.02% 774
2016
Q1
$17.1M Sell
649,632
-890,764
-58% -$65.9M 0.02% 796
2015
Q4
$157M Buy
1,540,396
+994,476
+182% +$112M 0.18% 114
2015
Q3
$97.4M Buy
545,920
+5,810
+1% +$1.35M 0.12% 177
2015
Q2
$120M Sell
540,110
-13,966
-3% -$3.1M 0.12% 179
2015
Q1
$110M Buy
554,076
+58,019
+12% +$10.3M 0.11% 193
2014
Q4
$71M Sell
496,057
-105,036
-17% -$14.1M 0.06% 323
2014
Q3
$78.9M Buy
601,093
+542
+0.1% +$64.6K 0.06% 313
2014
Q2
$75.7M Buy
600,551
+156,832
+35% +$20M 0.06% 319
2014
Q1
$58.5M Sell
443,719
-16,232
-4% -$2.22M 0.06% 360
2013
Q4
$54M Buy
+459,951
New +$50.4M 0.05% 384

Other funds holding BHC

Credit Suisse's BHC Position: Q1 2024 in Review

Credit Suisse reduced its Bausch Health (BHC) stake by 18% in Q1 2024, selling an estimated $1.05M and leaving 562,172 shares worth $5.96M. The position accounts for 0.01% of the portfolio, ranked #1195.

Credit Suisse first reported a position in BHC in Q4 2013 and has held it in 42 quarters since. The position peaked at $157M in Q4 2015. 237 funds tracked by Wall St. Rank hold BHC as of Q1 2024.

  • Credit Suisse held 562,172 shares of Bausch Health worth $5.96M as of Q1 2024.
  • Credit Suisse sold 120,146 Bausch Health shares in Q1 2024, an estimated $1.05M.
  • Bausch Health made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1195 holding.
  • Credit Suisse first reported a position in Bausch Health in Q4 2013 and has held it in 42 quarters since.
  • Credit Suisse's Bausch Health position peaked at $157M in Q4 2015.
  • 237 funds tracked by Wall St. Rank held Bausch Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.